CROSS-STANDARD public interest · Cosmetics & personal care

China-to-Australia Cosmetics Compliance Gap Matrix

AI-compiled from official public sources — cross-checked by multiple AI models, not human-verified. Informational only; see disclaimer. Public-interest, source-linked comparison of Chinese cosmetics compliance against Australian requirements for industrial chemical introduction, ingredient labelling, therapeutic-claim boundaries, and scheduled poisons.

Dataset 2026-06-11 Last verified 2026-06-12 5 rows

GAP MATRIX

Compliance Gap Matrix

Gap matrix
Compliance item Common China baseline Australia Gap / action Source + verification date
AICIS Categorisation of Cosmetic Ingredient Introductions China controls cosmetic ingredient use through the Inventory of Existing Cosmetic Ingredients in China, NMPA registration or notification, new cosmetic ingredient controls, and product safety assessment. These checks do not map one-to-one to AICIS introduction categories or the Australian Inventory of Industrial Chemicals.Inventory of Existing Cosmetic Ingredients in China (IECIC)
CSAR 2021 — new cosmetic ingredient and product safety assessment controls		 Before importing or manufacturing an industrial chemical for use in cosmetics, the introducer must categorise the introduction under AICIS. The category determines whether the introduction is listed, exempted, reported, assessed, or commercial evaluation, and whether records, annual declarations, pre-introduction reports, or assessment certificates are needed.Industrial Chemicals Act 2019 — introduction categories and assessment framework
Industrial Chemicals (General) Rules 2019 — categorisation, recordkeeping, and reporting rules		 Ingredients allowed in China may still require AICIS categorisation before Australian import. Exporters should provide the Australian importer with full INCI, CAS where available, concentration, function, nanoscale status, animal-test status if relevant, and use-pattern data so the importer can determine whether the chemical is listed on the Australian Inventory or requires an exempted, reported, or assessed pathway.[INFORMATIONAL] Treat AICIS categorisation as a pre-import ingredient-by-ingredient gate; do not rely on NMPA ingredient acceptance alone. Australian Industrial Chemicals Introduction Scheme (AICIS)2026-06-12 · unverified
AICIS Registration for Australian Importers of Cosmetic Ingredients China regulates cosmetic registrants, notifiers, domestic responsible persons, manufacturers, and ingredient use through CSAR 2021 and NMPA systems. A Chinese NMPA filing or registration is not equivalent to an Australian AICIS business registration for the importer or manufacturer introducing industrial chemicals in Australia.Cosmetic Supervision and Administration Regulation (CSAR) 2021 — registrant and notifier obligations
NMPA cosmetic registration and notification requirements for cosmetic products and ingredients		 Businesses that import or manufacture industrial chemicals in Australia, including many chemicals used as cosmetic ingredients, generally must register with the Australian Industrial Chemicals Introduction Scheme (AICIS) before introducing those chemicals. Registration is a business-level obligation and is separate from product labelling, TGA classification, and customs entry.Industrial Chemicals Act 2019 — AICIS registration framework for industrial chemical introducers
Industrial Chemicals (General) Rules 2019 — operational requirements for registered introducers		 For China-to-Australia supply, the Australian importer, not merely the Chinese brand owner, must check AICIS registration before importing finished cosmetics or bulk ingredients containing industrial chemicals. A Chinese compliance dossier does not replace AICIS registration, and missing registration can block lawful chemical introduction even where the finished product is otherwise labelled as a cosmetic.[INFORMATIONAL] Confirm the Australian importer or manufacturer is registered with AICIS before first import of cosmetics containing industrial chemicals, unless a specific exemption applies. Australian Industrial Chemicals Introduction Scheme (AICIS)2026-06-12 · unverified
Consumer Goods (Cosmetics) Information Standard 2020 Ingredient Labelling under Australian Consumer Law China requires cosmetic labels to disclose ingredients and other mandatory product information under CSAR 2021, NMPA labelling measures, and GB 5296.3. Chinese domestic labels are normally in Chinese and are prepared for NMPA and China consumer disclosure requirements.GB 5296.3 — Instructions for use of consumer products — Cosmetics
NMPA Administrative Measures for Cosmetic Labelling		 Cosmetic products supplied in Australia must comply with the mandatory cosmetics ingredient labelling information standard. Ingredient information generally must be provided on the container or the product itself, and ingredients must be listed in descending order by volume or mass, with smaller-concentration ingredients allowed after the main ingredients according to the standard.Consumer Goods (Cosmetics) Information Standard 2020 / Consumer Goods (Cosmetics) Information Standard 2020
Australian Consumer Law — mandatory information standards for consumer goods		 A Chinese label cannot be assumed to satisfy Australia. The Australian label should be checked against the local ingredient information standard, including placement, ingredient order, nomenclature, small-package treatment, and any ACL misleading conduct risk. Claims and ingredient names translated from Chinese marketing copy should be reviewed separately.[INFORMATIONAL] Prepare an Australia-specific ingredient label and verify it against the ACCC-administered mandatory information standard before supply. Australian Competition and Consumer Commission (ACCC)2026-06-12 · unverified
SUSMP / Poisons Standard Screening for Cosmetic Ingredients China controls prohibited and restricted cosmetic ingredients through NMPA lists, technical safety specifications, and product safety assessment. Those lists do not replace Australian poisons scheduling, which may classify the same chemical differently and may impose supply-chain controls outside cosmetic labelling rules.Safety and Technical Standards for Cosmetics — prohibited and restricted substances
CSAR 2021 — cosmetic safety assessment and ingredient compliance obligations		 Cosmetic ingredients may be affected by the Standard for the Uniform Scheduling of Medicines and Poisons, commonly called the Poisons Standard or SUSMP. Scheduled substances can trigger concentration limits, warning statements, packaging controls, supply restrictions, or state and territory poisons-law obligations even when the finished product is marketed as a cosmetic.Therapeutic Goods (Poisons Standard) Instrument — current Poisons Standard / SUSMP
State and territory poisons legislation adopting or applying SUSMP schedules		 Before export, screen active-like ingredients, preservatives, acids, hair dyes, depilatories, anti-dandruff agents, solvents, and high-concentration botanicals against the current Poisons Standard and relevant state or territory rules. A substance permitted in China at a cosmetic concentration may still need Australian warning, packaging, scheduling, or supply controls.[INFORMATIONAL] Include SUSMP screening in the ingredient review; Australian poisons controls can apply alongside AICIS, ACCC labelling, and TGA boundary analysis. Federal Register of Legislation / Office of Parliamentary Counsel2026-06-12 · unverified
Therapeutic-Claim Boundary between Cosmetics and TGA-Regulated Goods China also prohibits cosmetics from claiming medical effects, but Chinese special cosmetic categories and accepted functional claims do not automatically determine Australian TGA status. Claims such as anti-acne, repair of eczema, treatment of dandruff, antibacterial disease prevention, or sunscreen use may require separate Australian classification analysis.CSAR 2021 — cosmetics must not claim medical effects
NMPA Administrative Measures for Cosmetic Labelling — prohibited medical and false claims		 In Australia, a product promoted for therapeutic use, or represented with therapeutic claims such as treating, preventing, or curing disease or a medical condition, may be a therapeutic good regulated by the Therapeutic Goods Administration. A product presented as a cosmetic in China may still fall within the TGA framework if Australian presentation, claims, ingredients, or intended use cross the therapeutic boundary.Therapeutic Goods Act 1989 — definition and regulation of therapeutic goods
TGA guidance on whether a product is a cosmetic or therapeutic good		 Review all Australian-facing pack copy, website copy, marketplace listings, influencer scripts, and Chinese-to-English translations for therapeutic wording. If therapeutic claims remain, the product may require ARTG entry or another TGA pathway before import or supply; if the product is kept as a cosmetic, claims should be revised to cosmetic-only presentation supported by evidence.[INFORMATIONAL] Do a TGA boundary review before Australian launch; therapeutic claims can move a cosmetic into therapeutic goods regulation. Therapeutic Goods Administration (TGA)2026-06-12 · unverified

E-E-A-T

Named editorial review

Pending named reviewer

Official regulator, standards body, notified body, customs, or primary legal source preferred. Local PDFs are not accepted.

Editorial controls

Rows must include publisher, official URL, access date, verification flag, and last_verified before human_reviewed can be true.

SOURCES

Official-source register.